Boston Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Boston Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11040
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Boston Pharmaceuticals Inc (Boston Pharma) is a drug development company that develops new drugs for unmet needs. The company acquires and advances various drug candidates from investigational new drug application (IND) through Phase 2 including BOS161721, BOS172767, BOS173717, BOS172722, BOS172738, BOS1728515 and BOS162262. Its drug candidates asre used in the therapeutic areas of auto-immune, oncology, cardiology and anti-infective. The company also acquires molecules from pharmaceutical and biotechnology companies and transform them into various therapeutics that improve patients’ lives. Boston Pharma is headquartered in Cambridge, Massachusetts, the US.

Boston Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Boston Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Boston Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Boston Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Boston Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Boston Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Boston Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Boston Pharma Raises USD600 Million in Financing Round 10
Licensing Agreements 11
Boston Pharma Enters into Licensing Agreement with Novartis 11
Boston Pharma Enters into Licensing Agreement with GlaxoSmithKline 12
Boston Pharma Enters into Licensing Agreement Laboratoires Pierre 13
Daiichi Sankyo Enters into Licensing Agreement with Boston Pharma 14
Boston Pharmaceuticals Inc – Key Competitors 15
Boston Pharmaceuticals Inc – Key Employees 16
Boston Pharmaceuticals Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Strategy And Business Planning 18
Oct 04, 2018: Novartis licences anti-infective candidates to Boston Pharmaceuticals 18
Corporate Communications 19
Jan 03, 2018: Boston Pharmaceuticals Appoints Dr. Peter Ho as Chief Medical Officer 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Boston Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
Boston Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Boston Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Boston Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Boston Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Boston Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Boston Pharma Raises USD600 Million in Financing Round 10
Boston Pharma Enters into Licensing Agreement with Novartis 11
Boston Pharma Enters into Licensing Agreement with GlaxoSmithKline 12
Boston Pharma Enters into Licensing Agreement Laboratoires Pierre 13
Daiichi Sankyo Enters into Licensing Agreement with Boston Pharma 14
Boston Pharmaceuticals Inc, Key Competitors 15
Boston Pharmaceuticals Inc, Key Employees 16

List of Figures
Boston Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Boston Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Boston Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Boston Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Boston Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Boston Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Boston Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Boston Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Boston Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ellie Mae Inc (ELLI):企業の財務・戦略的SWOT分析
    Summary Ellie Mae Inc (Ellie Mae) is a technology company that provides cloud-based technology solutions, online network, software and services for the residential mortgage industry. It offers network applications that enable mortgage originators such as mortgage bankers and mortgage brokers, commun …
  • Mars, Incorporated:企業の戦略・SWOT・財務情報
    Mars, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Mars, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • National Company KazMunayGas:石油・ガス:M&Aディール及び事業提携情報
    Summary National Company KazMunayGas (KazMunayGas) is a state-owned, vertically integrated oil and gas company. It carries out the acquisition, exploration, development, production, processing, transportation, refining and export of hydrocarbons. The company also produces petrochemicals, stores and …
  • Astron Corp Ltd (ATR):企業の財務・戦略的SWOT分析
    Astron Corp Ltd (ATR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Avista Corporation
    Avista Corporation - Strategy, SWOT and Corporate Finance Report Summary Avista Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Logicbio Therapeutics Inc (LOGC):製薬・医療:M&Aディール及び事業提携情報
    Summary Logicbio Therapeutics Inc (Logicbio) is a genome-editing company with focus on the development of transformative medicines for the treatment of hematological and genetic disorders. Its pipeline product candidates include LB-101 for treating Hemophilia B; LB-201 against inborn error of metabo …
  • Butterfield Private Banking:企業の戦略・SWOT・財務情報
    Butterfield Private Banking - Strategy, SWOT and Corporate Finance Report Summary Butterfield Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • TE Connectivity Ltd (TEL):企業の財務・戦略的SWOT分析
    TE Connectivity Ltd (TEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Fukoku Mutual Life Insurance Company:企業の戦略・SWOT・財務情報
    Fukoku Mutual Life Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Fukoku Mutual Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • CITIC Ltd (267):電力:M&Aディール及び事業提携情報
    Summary CITIC Limited (CITIC) is a conglomerate company, operating in financial services, resources and energy, manufacturing, engineering contracting, real estate, and other businesses. Financial services include insurance, trust, security, and banking. Resources and energy comprises electricity ge …
  • Sutter Health:製薬・医療:M&Aディール及び事業提携情報
    Summary Sutter Health (Sutter Health) is a non-profit healthcare service provider, which provides health care service through its hospitals, ambulatory surgery centers, cardiac centers, cancer centers, rehabilitation centers and others. It serves communities across Northern California- in the San Fr …
  • Koch Enterprises, Inc.:企業の戦略的SWOT分析
    Koch Enterprises, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • AnaBios Corp-製薬・医療分野:企業M&A・提携分析
    Summary AnaBios Corp (AnaBios) is a pre-clinical stage contract research organization which carries out drug efficacy studies on human samples. Its products portfolio includes human dorsal root ganglia (hDRG) neuron cultures, human heart tissue samples,human cardiac mesenchymal stem cells, human bra …
  • Consumers Energy Co:企業の発電所・SWOT分析2018
    Consumers Energy Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • SurgaColl Technologies Ltd:製品パイプライン分析
    Summary SurgaColl Technologies Ltd (SurgaColl Technologies) is a medical device company that develops regenerative technologies. The company’s products comprise hydroxycoll and chondrocoll. It offers regenerative solutions in the field of bone, cartilage and osteochondral tissue regeneration. SurgaC …
  • Provectus Biopharmaceuticals Inc (PVCT)-医療機器分野:企業M&A・提携分析
    Summary Provectus Biopharmaceuticals Inc (Provectus), formerly Provectus pharmaceuticals Inc is a biotechnology company that develops pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for recurrent melanoma, PV-10 for metastatic liver canc …
  • AGL Energy Limited:企業の戦略・SWOT・財務分析
    AGL Energy Limited - Strategy, SWOT and Corporate Finance Report Summary AGL Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Superior Industries International, Inc.:企業の戦略・SWOT・財務分析
    Superior Industries International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Superior Industries International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Minnesota Municipal Power Agency:企業の戦略的SWOT分析
    Minnesota Municipal Power Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Vitruvian Exploration II LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Vitruvian Exploration II LLC (Vitruvian Exploration II) is an oil and gas company that provides exploration and development of oil properties. The company provides exploration of onshore North American unconventional oil and gas resource plays. Its VEX II Woodford Apollo project has various …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆